Pliant Therapeutics competitors and similar companiesClear all

Pliant Therapeutics's competitors and similar companies include Xenikos, Angion Biomedica, Kadmon and Galapagos.
Pliant Therapeutics
Pliant Therapeutics
Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases.
Xenikos
Xenikos
Xenikos is a clinical-stage biopharmaceutical company.
Angion Biomedica
Angion Biomedica
Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury.
Kadmon
Kadmon
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
Galapagos
Galapagos
Galapagos is a biotechnology company.
Founding Date
Founding Date
2016
Founding Date
2012
Founding Date
1998
Founding Date
2010
Founding Date
1999
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Nijmegen, NL HQ
Locations
San Francisco, US HQ
Uniondale, US
Locations
New York, US HQ
Cambridge, US
South Brunswick Township, US
Warrendale, US
Locations
Mechelen, BE HQ
Romainville, FR
Leiden, NL
Basel, CH
Waltham, US
Employees
Employees
1224% increase
Employees
18
Employees
53
Employees
1151% decrease
Employees
1,305
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2.7 b
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
111
Twitter followers
N/A
Twitter followers
49
Alexa Website Rank
Alexa Website Rank
504312
Alexa Website Rank
N/A
Alexa Website Rank
341723
Alexa Website Rank
N/A
Alexa Website Rank
336284
Employee Rating
Employee Rating
4.4
Employee Rating
N/A
Employee Rating
2.7
Employee Rating
2.8
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$28.3m (FY, 2021)
Revenue (est.)
$8.3m (FY, 2020)
Revenue (est.)
€484.8m (FY, 2021)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$433k (FY, 2021)
Cost of goods
N/A
Cost of goods
€1.6m (FY, 2021)
Net income
Net income
N/A
Net income
N/A
Net income
($54.6m) (FY, 2021)
Net income
($108.9m) (FY, 2020)
Net income
(€103.2m) (FY, 2021)

Funding

Latest funding round
Latest funding round
$ 62m (over 4 years ago)
Latest funding round
$ 30m (over 4 years ago)
Latest funding round
$ 15.4m (over 4 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 107m
Total funding raised
$ 37m
Total funding raised
$ 19.7m
Total funding raised
$ 21.3m
Total funding raised
$ 3.7m
For sources of this data, please see the company profile

View company profiles

Xenikos
HQ
Nijmegen, NL
Employees
18

Xenikos is a clinical-stage biopharmaceutical company.

View company
Angion Biomedica
HQ
San Francisco, US
Employees
53

Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury.

View company
Kadmon
HQ
New York, US
Employees
115↓ 1% decrease

Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.

View company
Galapagos
HQ
Mechelen, BE
Employees
1,305

Galapagos is a biotechnology company.

View company